Enzychem Lifesciences Corporation (183490.KQ) KOE

Currency In KRW

Enzychem Lifesciences Corporation

Address

aT Center

Seoul,

Korea (the Republic of)

Phone

82 1 201 321 6976

Website

http://www.enzychem.com

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

122

First IPO Date

April 05, 2017

Key Executives

Name	Title	Pay	Year Born
Ki-Young Sohn	Chairman & Chief Executive Officer	0	N/A
Jeff Clark	Chief Licensing Officer	0	N/A
John Choi	Executive Director	0	N/A
G. Alexander Fleming	Member of Corporate Advisory Committee & Chief Technology Officer	0	N/A
Myung-Hwan Kim	CMO & Director	0	N/A
Jae-Yong Lee	Vice President & Executive Director	0	N/A
Do-Young Lee	Chief Scientific Officer & Member of the Board of Directors	0	N/A

Description

Enzychem Lifesciences Corporation, a pharmaceutical company, primarily dedicates itself to formulating oral, small-molecule therapies aimed at addressing urgent unmet medical needs for patients in South Korea suffering from conditions in oncology, metabolic diseases, and inflammatory disorders. Furthermore, the firm is actively developing innovative treatments utilizing its EC-18 technology platform to combat chemotherapy-induced neutropenia, oral mucositis triggered by chemoradiation therapy, and acute radiation syndrome. Founded in 1999, its headquarters are situated in Seoul, South Korea.